Physician profile
Chad J Davis
NPI 1619938073
$10,573.30
in general payments reported to CMS, 2019-2025
23 companies · $39.20 in 2025
The $39.20 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $8,629 · 2021: $568 · 2022: $371 · 2023: $254 · 2024: $214 · 2025: $39.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391 · Travel and Lodging: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.13 |
| Travel and Lodging | $116.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,605.30 | 2019-2020 | |
| Organogenesis INC. | $408.87 | 2022-2024 | Puraply, Nushield |
| Abbvie INC. | $363.88 | 2019-2022 | |
| Davol INC. | $224.71 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.39 | 2020-2022 | |
| Ethicon US, LLC | $97.94 | 2019-2022 | |
| Misonix INC | $91.41 | 2020 | |
| Nestle Healthcare Nutrition INC. | $88.35 | 2021-2022 | |
| Smith+Nephew, INC. | $84.33 | 2020-2025 | Collagenase Santyl, Regranex |
| Integra Lifesciences Corporation | $78.29 | 2021 | |
| Kerecis Limited | $76.36 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tactile Systems Technology INC | $48.50 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Innocoll Pharmaceuticals Limited | $45.31 | 2021 | |
| Heron Therapeutics, INC. | $43.18 | 2021-2022 | |
| Hologic Sales and Service, LLC | $39.34 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $26.20 | 2019 | |
| Medtronic, INC. | $25.50 | 2021 | |
| Mallinckrodt Hospital Products INC. | $24.31 | 2021 | |
| Polynovo North America LLC | $21.01 | 2023 | |
| Boston Scientific Corporation | $18.26 | 2019 | |
| Tela Bio, INC. | $14.07 | 2022 | |
| Merck Sharp & Dohme LLC | $12.68 | 2019 | |
| Asensus Surgical, INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.